Elevated serum levels of the soluble form of gp130, the IL-6 signal transducer, in HTLV-1 infection and no involvement of alternative splicing for its generation

Microbiology and Immunology

Volumn 42, Issue 2, 1998, Pages 109-116

  Zhou, Yongwei ^a   Horiuchi, Sankichi ^a   Yamamoto, Mikio ^b   Yamamoto, Naoki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Alternative splicing; ATL; HAM; HTLV 1; Proteolytic cleavage; Soluble gp130

Indexed keywords

GLYCOPROTEIN GP 130; INTERLEUKIN 6; MESSENGER RNA;

ALTERNATIVE RNA SPLICING; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE DELETION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; MONONUCLEAR CELL; NUCLEOTIDE SEQUENCE; PROTEIN DEGRADATION; PROTEIN DOMAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T CELL LEUKEMIA;

EID: 0031888288     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.1998.tb02258.x     Document Type: Article

References (35)

1. Arrigo, S.J., Wettsman, S., Rosenblatt, J.D., and Chen, I.S.Y. 1989. Analysis of rev gene function on human immunodeficiency virus type 1 replication in lymphoid cells by using quantitative polymerase chain reaction method. J. Virol. 63: 4875-4881.
2. Chen, L., Mory, Y., Zilberstein, A., and Revel, M. 1988. Growth inhibition of human breast carcinoma and leukemia/ lymphoma cell lines by recombinant interferon-B2. Proc. Natl. Acad. Sci. U.S.A. 85: 8037-8041.
3. Gearing, D.P., Comeau, M.R., Friend, D.J., Gimpel, S.D., Thut, C.J., McGourty, J., Brasher, K.K., Kind, J.A., Gills, S., Mosley, B., Ziagler, S.F., and Cosman, D. 1992. The IL-6 signal transducer, gp130: an Oncostatin M receptor and affinity converter for the LIF receptor. Science 255: 1434-1437.
4. Gearing, D.P., and Bruce, A.G. 1992. Oncostatin M binds the high affinity leukemia inhibitory factor receptor. New Biol. 4: 61-65.
5. Heaney, M.L., and Golde, D.W. 1996. Soluble cytokine receptors. Blood 87: 847-857.
6. Hibi, M., Murakami, M., Saito, M., Hirano, T., Taga, T., and Kishimoto, T. 1990. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 63: 1149-1157.
7. Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S., Nakajima, K., Koyama, K., Iwamatsu, A., Tsunasawa, S., Sakiyama, F., Matsui, H., Takahara, Y., Taniguchi, T., and Kishimoto, T. 1986. Complementary DNA for a novel human interleukin (BSF-2) that induce B lymphocytes to produce immunoglobulin. Nature 324: 73-76.
8. Honda, M., Yamamoto, S., Cheng, M., Yasukawa, K., Suziki, H., Saito, T., Osugi, Y., Tokunaga, T., and Kishimoto, T. 1992. Human soluble IL-6 receptor: its detection and enhanced release by HIV infection. J. Immunol. 148: 2175-2180.
9. Hori, Y., Muraguchi, A., Iwano, M., Matsuda, T., Hirayama, T., Yamada, H., Fujii, Y., Dohi, K., Ishikawa, H., Ohmoto, Y., Yoshizaki, K., Hirano, T., and Kishimoto, T. 1989. Involvement of interleukin-6 in mesanginal proliferative glomerulonephritis. J. Immunol. 143: 3949-3955.
10. Horiuchi, S., Koyanagi, Y., Tanaka, Y., Waki, M., Matsumoto, A., Zhou, Y.W., Yamamoto, M., and Yamamoto, N. 1997. Altered interleukin-2 receptor α-chain is expressed in human T-cell leukaemia virus type-I infected T-cell lines and human peripheral blood mononuclear cells of adult T-cell leukaemia patients through an alternative splicing mechanism. Immunology 91: 28-34.
11. Horiuchi, S., Koyanagi, Y., Zhou, Y., Miyamoto, H., Tanaka, Y., Waki, M., Matsumoto, A., Yamamoto, M., and Yamamoto, N. 1994. Soluble interleukin-6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism. Eur. J. Immunol. 24: 1945-1948.
12. Ip, N.Y., Nye, S.H., Boulton, T.G., Davis, S., Taga, T., Li, Y., Birren, S.J., Yasukawa, K., Kishimoto, T., Anderson, D.J., Stahl, N., and Yancopoulos, G.D. 1992. CNTF and LIF act on neuronal cells via shared signaling pathway that involve the IL-6 signal transducing receptor component gp130. Cell 69: 1121-1132.
13. Ishibashi, T., Kimura, H., Uchida, T., Kariyone, S., Friese, P., and Burstin, S.A. 1989. Human interleukin 6 is a direct promotor of maturation of megakaryocytes in vivo. Proc. Natl. Acad. Sci. U.S.A. 86: 5953-5957.
14. Ishimi, Y., Miyaura, C., He, J.C., Akatsu, T., Nakamura, Y., Yamaguchi, A., Yoshiki, S., Matsuda, T., Hirano, T., Kishimoto, T., and Suda, T. 1990. IL-6 is produced by osteoclasts and induces bone resorption. J. Immunol. 145: 3297-3303.
15. Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Iwato, K., Asaoku, H., Tang, B., Tanabe, O., Tanaka, H., Kuramoto, A., and Kishimoto, T. 1988. Autocrine generation and essential requirement of BSF-2/IL-6 for human multiple myeloma. Nature 332: 83-85.
16. Kopf, M., Baumann, H., Freer, G., Fredenberg, M., Lamers, M., Kishimoto, T., Zinkernagle, R., Bluethmann, H., and Kohler, G. 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 3681: 339-342.
17. Le, J., Fredrickson, G., Reis, L.F.L., Diamantsein, T., Hirano, T., Kishimoto, T., and Vilcek, J. 1988. Interleukin 2-dependent and interleukin 2-independent pathways of regulation of thymocyte function by interleukin 6. Proc. Natl. Acad. Sci. U.S.A. 85: 8643-8647.
18. Lotz, M., Jirik, F., Kabouridis, R., Tsoukas, C., Hirano, T., Kishimoto, T., and Carson, D.A. 1988. BSF/IL-6 is a costimulant for human thyocytes and lymphocytes. J. Exp. Med. 167: 1253-1258.
19. Miki, S., Iwano, M., Miki, Y., Yamamoto, M., Tang, B., Yokokawa, K., Hirano, T., and Kishimoto, T. 1989. Involvement of interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett. 250: 607-610.
20. Miles, S.A., Rezai, A.R., Salszas-Gonzalez, J.F., Meyden, M. V., Stevens, R.H., Logan, D.M., Mitsutasu, R.T., Taga, T., Hirano, T., Kishimoto, T., and Martinez-Maza, O. 1990. AIDS Kaposi's sarcoma-derived cells produce and respond to interleukin 6. Proc. Natl. Acad. Sci. U.S.A. 87: 4068-4072.
21. Miyaura, C., Onozaki, K., Akiyama, Y., Taniyama, T., Hirano, T., Kishimoto, T., and Suda, T. 1988. Recombinant human interleukin 6 (B-cell stimulatory factor 2) is a potent inducer of differentiation of mouse myeloid leukemia cells (M1). FEBS. Lett. 234: 17-21.
22. Mullberg, J., Schooltink, H., Stoyan, T., Gunther, M., Graeve, L., Buse, G., Mackiewicz, A., Heinrich, P.C., and Rose-John, S. 1993. The soluble interleukin-6 receptor is generated by shedding. Eur. J. Immunol. 23: 473-480.
23. Narazaki, M., Yasukawa, K., Saito, T., Ohsugi, Y., Fukui, H., Koishihara, Y., Yancopoulos, G.D., Taga, T., and Kishimoto, T. 1993. Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130. Blood 82: 1120-1126.
24. Okamoto, Y., Yoshizaki, H., Nakasone, T., Kitamura, K., and Honda, M. 1993. Role of soluble IL-6 signal transducer (gp130) in HIV infection. Nippon-Rinsho 51: 68-72.
25. Paonessa, G., Graziani, R., Serio, A.D., Svino, R., Ciapponi, L., Lahm, A., Salvati, A.L., Tniatti, C., and Ciliberto, G. 1995. Two distinct and independent sites on IL-6 trigger gp130 dimer formation and signaling. EMBO J. 14: 1942-1951.
26. Pennica, D., Shaw, T.A., Swanson, M.W., Moore, D.L., Sjelton, K.A., Zioncheck, A., Rosenthal, A., Taga, T., Paoni, N.F., and Wood, W.I. 1995. Cardiotrophin-1.Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J. Biol. Chem. 270: 10915-10922.
27. Ramsay, A.J., Husband, A.J., Ramshaw, I.A., Bao, S., Matthaei, K.I., Koehler, G., and Kopf, M. 1994. The role of interleukin-6 in mucosal IgA antibody responses in vitro. Science 264: 561-563.
28. Satoh, T., Nakamura, S., Taga, T., Matsuda, T., Hirano, T., Kishimoto, T., and Kaziro, Y. 1988. Induction of neural differentiation in PC12 cells by B cell stimulatory factor 2/interleukin 6. Mol. Cell. Biol. 8: 3546-3549.
29. Taga, T., Hibi, M., Hirata, Y., Yamasaki, K., Yasukawa, K., Matsuda, T., Hirano, T., and Kishimoto, T. 1989. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 58: 573-581.
30. Van Snick, J. 1990. Interleukin-6: an overview. Annu. Rev. Immunol. 8: 253-278.
31. Vieira, J., and Messing, J. 1987. Production of single-strand plasmid DNA. Methods Enzymol. 153: 3-11.
32. Yamasaki, K., Taga, T., Hirata, Y., Yawata, H., Kawanishi, Y., Seed, B., Taniguchi, T., Hirano, T., and Kishimoto, T. 1988. Cloning and expression of human interleukin-6 (BSF-2/IFN B2) receptor. Science 241: 825-828.
33. Yasukawa, K., Futatsugi, K., Saito, T., Yawata, H., Narazaki, M., Suziki, H., Taga, T., and Kishimoto, T. 1992. Association of recombinant soluble IL-6-signal transducer, gp130, with a complex of IL-6 and soluble IL-6 receptor, and establishment of an ELISA for soluble gp130. Immunol. Lett. 31: 123-130.
34. Yin, T., Taga, T., Tsang, M.L.S., Yasukawa, K., Kishimoto, T., and Yang, Y.C. 1993. Involvement of IL-6 signal transducer gp130 in IL-11-mediated signal transduction. J. Immumol. 151: 2555-2561.
35. Yoshizaki, K., Nishimoto, N., Matsumoto, K., Tagoh, H., Taga, T., Deguchi, Y., Kuritani, T., Hirano, T., Hashimoto, K., Okada, N., and Kishimoto, T. 1990. Interleukin 6 and expression of its receptor on epidermal keratinocytes. Cytokine 2: 381-387.